| Phase 4 |
| NCT05874570 |
Doxycycline for Helicobacter Pylori Rescue Treatment |
Helicobacter Pylori Infection |
Recruiting |
| NCT06561698 |
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter… |
Helicobacter Pylori Infection |
Recruiting |
| NCT06930157 |
Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent… |
Low-risk Colorectal Adenoma |
Recruiting |
| NCT05843292 |
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy… |
Triple-negative Breast Cancer |
Not Yet Recruiting |
| NCT04111419 |
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With… |
Atrial Fibrillation |
Active, Not Recruiting |
| Phase 3 |
| NCT06829472 |
Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of… |
Toxicities |
Recruiting |
| NCT05991908 |
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating… |
Acute Myeloid Leukemia |
Recruiting |
| NCT06705062 |
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in… |
Allogeneic Hematopoietic Cell Transplant |
Recruiting |
| NCT02455141 |
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast… |
Breast Neoplasm |
Active, Not Recruiting |
| NCT07060391 |
A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the… |
Alzheimer's Disease |
Not Yet Recruiting |
| NCT03932136 |
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) |
Clinical High Risk Syndrome of Psychosis |
Active, Not Recruiting |
| NCT07761702 |
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML |
AML (Acute Myelogenous Leukemia) |
Not Yet Recruiting |
| Phase 2/3 |
| NCT05125055 |
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC |
Oral Squamous Cell Carcinoma |
Recruiting |
| NCT06607419 |
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed… |
B-Cell Lymphoblastic Leukemia |
Recruiting |
| NCT03258320 |
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus… |
Prostate Cancer Patients |
Recruiting |
| Phase 2 |
| NCT02290145 |
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at… |
Mouth Neoplasms |
Recruiting |
| NCT05069857 |
Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients |
Oral Squamous Cell Carcinoma |
Recruiting |
| NCT03326947 |
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC |
Neoplasm Neck |
Recruiting |
| NCT04183712 |
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA |
Gallbladder Carcinoma |
Recruiting |
| NCT05891561 |
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early… |
Breast Cancer |
Recruiting |
| NCT05870995 |
Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory… |
Refractory Leukemia |
Recruiting |
| NCT05881265 |
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute… |
APL |
Recruiting |
| NCT06500208 |
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC |
Breast Cancer |
Recruiting |
| NCT07371208 |
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination… |
Breast Cancer |
Recruiting |
| NCT07393425 |
Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer |
HER2 + Breast Cancer |
Recruiting |